On a molecular level, ceramides have been reported to activate inflammatory pathways in several abnormal physiological circumstances involving insulin resistance, mitochondrial dysfunction and endoplasmatic reticulum stress (48–51), which are attributed to worsen the clinical condition of COVID-19 patients (52–54). Here, INS is linked to COVID-19.